Mabion

Mabion, a fully integrated CDMO located in central Europe, was established in 2007 to develop and support the development of protein-based biotherapeutics, including monoclonal antibodies, vaccine antigens and other large proteins. With 17 years of experience, Mabion offers an ‘end-to-end solution, covering all stages of biologic drug development: from early clone selection and small-scale manufacturing through process scale-up, bioanalytical testing, large-scale manufacturing to sterile fill-finish, packaging and serialization. With broad capabilities and well-qualified, experienced staff, Mabion is a perfect long-term partner for any project involving therapeutic proteins, whether your product is in pre-clinical or clinical development or already commercially available.